inline pressure transducer mlt0670 Search Results


transducer  (ADInstruments)
95
ADInstruments transducer
The decrease in NO levels in vivo following the ingestion of HFD and L-NAME decreased the activity of the NO-sGC-cGMP pathway. cGMP-activated PKG has hypotensive, anti-inflammatory, and anti-fibrotic effects; therefore, decreased activity of the NO-sGC-cGMP pathway may lead to inflammation, hypertrophy, and apoptosis, leading to the development of HFpEF. Furthermore, the decrease in NO levels in vivo converts Ang I to Ang II; hence, a decrease in NO activates RAS. Ang II increased by RAS activity increases TGF-β expression, which consequently activates the MAPK signaling pathway, leading to fibroblast proliferation, ECM overdeposition, and fibrosis. Ang II also activates the PI3K-Akt and JAK-STAT signaling pathways, which may trigger inflammation, hypertrophy, and apoptosis, leading to HFpEF development. Early administration of the RAS inhibitors Cap and Sac/Val may suppress downstream signaling by inhibiting RAS, thereby reducing inflammation and fibrosis and preventing the onset of HFpEF. NO: nitric oxide; HFD: high-fat diet; L-NAME: NG-Nitro-L-arginine methyl ester; sGC: soluble guanylate cyclase; cGMP: cyclic guanosine monophosphate; PKG: protein kinase G; Ang I: angiotensin I; Ang II: angiotensin II; RAS: renin-angiotensin system; TGF-β: transforming growth factor-β; MAPK: mitogen-activated protein kinase; ECM: extracellular matrix; PI3K: phosphatidylinositol-3 kinase; Akt: serine/threonine protein kinase; JAK: janus kinase; STAT: signal <t>transducer</t> and activator of transcription.
Transducer, supplied by ADInstruments, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transducer/product/ADInstruments
Average 95 stars, based on 1 article reviews
transducer - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
disposable transducer model no. mlt 0670  (POWERLAB INC)
90
POWERLAB INC disposable transducer model no. mlt 0670
The decrease in NO levels in vivo following the ingestion of HFD and L-NAME decreased the activity of the NO-sGC-cGMP pathway. cGMP-activated PKG has hypotensive, anti-inflammatory, and anti-fibrotic effects; therefore, decreased activity of the NO-sGC-cGMP pathway may lead to inflammation, hypertrophy, and apoptosis, leading to the development of HFpEF. Furthermore, the decrease in NO levels in vivo converts Ang I to Ang II; hence, a decrease in NO activates RAS. Ang II increased by RAS activity increases TGF-β expression, which consequently activates the MAPK signaling pathway, leading to fibroblast proliferation, ECM overdeposition, and fibrosis. Ang II also activates the PI3K-Akt and JAK-STAT signaling pathways, which may trigger inflammation, hypertrophy, and apoptosis, leading to HFpEF development. Early administration of the RAS inhibitors Cap and Sac/Val may suppress downstream signaling by inhibiting RAS, thereby reducing inflammation and fibrosis and preventing the onset of HFpEF. NO: nitric oxide; HFD: high-fat diet; L-NAME: NG-Nitro-L-arginine methyl ester; sGC: soluble guanylate cyclase; cGMP: cyclic guanosine monophosphate; PKG: protein kinase G; Ang I: angiotensin I; Ang II: angiotensin II; RAS: renin-angiotensin system; TGF-β: transforming growth factor-β; MAPK: mitogen-activated protein kinase; ECM: extracellular matrix; PI3K: phosphatidylinositol-3 kinase; Akt: serine/threonine protein kinase; JAK: janus kinase; STAT: signal <t>transducer</t> and activator of transcription.
Disposable Transducer Model No. Mlt 0670, supplied by POWERLAB INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/disposable transducer model no. mlt 0670/product/POWERLAB INC
Average 90 stars, based on 1 article reviews
disposable transducer model no. mlt 0670 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
blood pressure transducer  (ADInstruments)
97
ADInstruments blood pressure transducer
The decrease in NO levels in vivo following the ingestion of HFD and L-NAME decreased the activity of the NO-sGC-cGMP pathway. cGMP-activated PKG has hypotensive, anti-inflammatory, and anti-fibrotic effects; therefore, decreased activity of the NO-sGC-cGMP pathway may lead to inflammation, hypertrophy, and apoptosis, leading to the development of HFpEF. Furthermore, the decrease in NO levels in vivo converts Ang I to Ang II; hence, a decrease in NO activates RAS. Ang II increased by RAS activity increases TGF-β expression, which consequently activates the MAPK signaling pathway, leading to fibroblast proliferation, ECM overdeposition, and fibrosis. Ang II also activates the PI3K-Akt and JAK-STAT signaling pathways, which may trigger inflammation, hypertrophy, and apoptosis, leading to HFpEF development. Early administration of the RAS inhibitors Cap and Sac/Val may suppress downstream signaling by inhibiting RAS, thereby reducing inflammation and fibrosis and preventing the onset of HFpEF. NO: nitric oxide; HFD: high-fat diet; L-NAME: NG-Nitro-L-arginine methyl ester; sGC: soluble guanylate cyclase; cGMP: cyclic guanosine monophosphate; PKG: protein kinase G; Ang I: angiotensin I; Ang II: angiotensin II; RAS: renin-angiotensin system; TGF-β: transforming growth factor-β; MAPK: mitogen-activated protein kinase; ECM: extracellular matrix; PI3K: phosphatidylinositol-3 kinase; Akt: serine/threonine protein kinase; JAK: janus kinase; STAT: signal <t>transducer</t> and activator of transcription.
Blood Pressure Transducer, supplied by ADInstruments, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/blood pressure transducer/product/ADInstruments
Average 97 stars, based on 1 article reviews
blood pressure transducer - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier
mlt0670 cable  (ADInstruments)
93
ADInstruments mlt0670 cable

Mlt0670 Cable, supplied by ADInstruments, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mlt0670 cable/product/ADInstruments
Average 93 stars, based on 1 article reviews
mlt0670 cable - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
pressure transducer  (ADInstruments)
93
ADInstruments pressure transducer

Pressure Transducer, supplied by ADInstruments, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pressure transducer/product/ADInstruments
Average 93 stars, based on 1 article reviews
pressure transducer - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
continuous arterial pressure  (ADInstruments)
98
ADInstruments continuous arterial pressure

Continuous Arterial Pressure, supplied by ADInstruments, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/continuous arterial pressure/product/ADInstruments
Average 98 stars, based on 1 article reviews
continuous arterial pressure - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier
mlac05 cables  (ADInstruments)
88
ADInstruments mlac05 cables

Mlac05 Cables, supplied by ADInstruments, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mlac05 cables/product/ADInstruments
Average 88 stars, based on 1 article reviews
mlac05 cables - by Bioz Stars, 2026-05
88/100 stars
  Buy from Supplier

Image Search Results


The decrease in NO levels in vivo following the ingestion of HFD and L-NAME decreased the activity of the NO-sGC-cGMP pathway. cGMP-activated PKG has hypotensive, anti-inflammatory, and anti-fibrotic effects; therefore, decreased activity of the NO-sGC-cGMP pathway may lead to inflammation, hypertrophy, and apoptosis, leading to the development of HFpEF. Furthermore, the decrease in NO levels in vivo converts Ang I to Ang II; hence, a decrease in NO activates RAS. Ang II increased by RAS activity increases TGF-β expression, which consequently activates the MAPK signaling pathway, leading to fibroblast proliferation, ECM overdeposition, and fibrosis. Ang II also activates the PI3K-Akt and JAK-STAT signaling pathways, which may trigger inflammation, hypertrophy, and apoptosis, leading to HFpEF development. Early administration of the RAS inhibitors Cap and Sac/Val may suppress downstream signaling by inhibiting RAS, thereby reducing inflammation and fibrosis and preventing the onset of HFpEF. NO: nitric oxide; HFD: high-fat diet; L-NAME: NG-Nitro-L-arginine methyl ester; sGC: soluble guanylate cyclase; cGMP: cyclic guanosine monophosphate; PKG: protein kinase G; Ang I: angiotensin I; Ang II: angiotensin II; RAS: renin-angiotensin system; TGF-β: transforming growth factor-β; MAPK: mitogen-activated protein kinase; ECM: extracellular matrix; PI3K: phosphatidylinositol-3 kinase; Akt: serine/threonine protein kinase; JAK: janus kinase; STAT: signal transducer and activator of transcription.

Journal: PLOS One

Article Title: Early administration of renin–angiotensin system inhibitors improves survival and cardiac remodeling in heart failure with preserved ejection fraction

doi: 10.1371/journal.pone.0339600

Figure Lengend Snippet: The decrease in NO levels in vivo following the ingestion of HFD and L-NAME decreased the activity of the NO-sGC-cGMP pathway. cGMP-activated PKG has hypotensive, anti-inflammatory, and anti-fibrotic effects; therefore, decreased activity of the NO-sGC-cGMP pathway may lead to inflammation, hypertrophy, and apoptosis, leading to the development of HFpEF. Furthermore, the decrease in NO levels in vivo converts Ang I to Ang II; hence, a decrease in NO activates RAS. Ang II increased by RAS activity increases TGF-β expression, which consequently activates the MAPK signaling pathway, leading to fibroblast proliferation, ECM overdeposition, and fibrosis. Ang II also activates the PI3K-Akt and JAK-STAT signaling pathways, which may trigger inflammation, hypertrophy, and apoptosis, leading to HFpEF development. Early administration of the RAS inhibitors Cap and Sac/Val may suppress downstream signaling by inhibiting RAS, thereby reducing inflammation and fibrosis and preventing the onset of HFpEF. NO: nitric oxide; HFD: high-fat diet; L-NAME: NG-Nitro-L-arginine methyl ester; sGC: soluble guanylate cyclase; cGMP: cyclic guanosine monophosphate; PKG: protein kinase G; Ang I: angiotensin I; Ang II: angiotensin II; RAS: renin-angiotensin system; TGF-β: transforming growth factor-β; MAPK: mitogen-activated protein kinase; ECM: extracellular matrix; PI3K: phosphatidylinositol-3 kinase; Akt: serine/threonine protein kinase; JAK: janus kinase; STAT: signal transducer and activator of transcription.

Article Snippet: The cannula was then connected to a transducer (MLT0670, BP transducer, AD Instruments, Oxford, UK), and blood pressure was continuously monitored for 10 min using the PowerLab® system (AD Instruments), with the average value calculated [ ].

Techniques: In Vivo, Activity Assay, Expressing, Protein-Protein interactions

Journal: STAR Protocols

Article Title: Protocol for perfusing human axillary lymph nodes ex vivo to study structure and function in real time

doi: 10.1016/j.xpro.2025.103624

Figure Lengend Snippet:

Article Snippet: DIN (8) to MLT0670 cable (3.9 m) , ADInstruments , Product Code: MLAC06.

Techniques: Recombinant, Targeted Gene Expression, Gene Expression, Control, Software, Sterility, Membrane